Jamshed Haneef | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Jamshed Haneef
Jamia Hamdard

Jamshed Haneef
Affiliation Jamia Hamdard
Country India
Scopus ID 55675642900
Documents 36
Citations 566
h-index 14
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0002-5520-6466

Jamshed Haneef is a researcher affiliated with Jamia Hamdard, India, whose supplied bibliometric profile identifies toxicology as the subject area. The reported Scopus record includes 36 documents, 566 citations and an h-index of 14. These indicators provide a quantitative overview of the publication and citation record associated with the identified author profile. The Innovative Research Award provides a recognition framework for examining research originality, methodological quality, scientific contributions and potential applications. This article presents the supplied profile information and discusses relevant considerations for evaluating research achievements without assuming unverified award decisions or attributing specific inventions to the researcher. [1]

Abstract

This article presents a research-profile overview of Jamshed Haneef, affiliated with Jamia Hamdard, India, with toxicology identified as the principal subject area in the supplied information. The reported Scopus metrics comprise 36 documents, 566 citations and an h-index of 14. These measures describe aspects of scholarly productivity and citation visibility but do not independently establish research quality, originality or practical impact. The profile is considered in the context of the Innovative Research Award associated with the International Invention Awards. Assessment of research distinction requires examination of verified publications, individual contributions, methodological rigor, innovation evidence and potential societal relevance. [1] [2]

Keywords

Jamshed Haneef; Innovative Research Award; International Invention Awards; Jamia Hamdard; India; toxicology; research evaluation; bibliometrics; scientific publications; citation analysis; h-index; research innovation; scholarly impact; research assessment.[1]

Introduction

Research recognition can help communicate scientific achievements and draw attention to work with potential value for academic or practical applications. In toxicology, research may address the effects of chemical, biological or environmental agents on living systems, including mechanisms of toxicity, exposure assessment and risk evaluation. Evaluating a researcher’s contributions requires consideration of the relevance and reliability of the underlying studies, alongside publication and citation information. [3]

Research Profile

Jamshed Haneef is listed in the supplied profile data as affiliated with Jamia Hamdard in India. The stated subject area is toxicology, a field concerned with the adverse effects of substances and the scientific assessment of exposure-related risks. The reported bibliometric indicators are 36 documents, 566 citations and an h-index of 14. The Scopus author identifier and ORCID supplied for this profile provide starting points for checking identity and publication records. [1] [4]

Research Contributions

Research contributions in toxicology may include identifying mechanisms of toxicity, characterizing hazardous exposures, evaluating biological responses and developing methods that improve safety assessment. Such work can support scientific understanding and inform decisions in areas including environmental health, pharmaceutical development and chemical risk management. The relevance of any contribution should be established through the researcher’s actual publications, study designs and documented findings rather than inferred solely from a subject-area label. [3]

Publications

The supplied Scopus profile reports 36 documents associated with the author identifier 55675642900. This count offers a broad indication of indexed scholarly output, but a complete publication review would need to establish the document types, publication dates, subject relevance and authorship details. A verified bibliography should be checked against the original publisher records and the researcher’s persistent identifiers to reduce the risk of author-name ambiguity.[5]

Research Impact

The reported 566 citations indicate that documents associated with the supplied profile have received scholarly citations within the relevant indexing record. The h-index of 14 represents a combined measure of publication output and citation distribution under the standard definition: at least 14 indexed publications have each received at least 14 citations, assuming the supplied metrics are accurate and refer to the same author record. These values can help describe scholarly visibility but may vary by database, coverage and retrieval date. [2]

Award Suitability

The Innovative Research Award, presented here in the context of the International Invention Awards, can be assessed through evidence of originality, research rigor, individual contribution and the potential value of the work. The reported publication and citation indicators offer useful background information, but award suitability cannot be established from bibliometric metrics alone. A fair evaluation would examine the candidate’s actual research outputs, the significance of the findings and the strength of supporting evidence.[5]

Conclusion

The supplied profile describes Jamshed Haneef as affiliated with Jamia Hamdard, India, and identifies toxicology as the subject area. It reports 36 documents, 566 citations and an h-index of 14 under the specified Scopus author identifier. These indicators provide a starting point for understanding the research record, but a comprehensive evaluation should also consider the content, rigor, originality and practical significance of individual contributions. Any formal recognition associated with the Innovative Research Award should be supported by verified award records and primary research documentation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Jamshed Haneef, Author ID 55675642900.
    https://www.scopus.com/authid/detail.uri?authorId=55675642900
  2. Journal article. (2023). Structural insights into mechanical anisotropy in ambrisentan polymorphs.
    https://doi.org/10.1039/d3ce00483j
  3. Journal article. (2022). Investigation of a Minocycline-Loaded Nanoemulgel for the Treatment of Acne Rosacea.
    https://doi.org/10.3390/pharmaceutics14112322
  4. ORCID. (n.d.). ORCID record: 0000-0002-5520-6466.
    https://orcid.org/0000-0002-5520-6466
  5. International Invention Awards. (2026.). Official award website.
    https://inventionawards.org/

Shiva Vairale | CSIR – National Chemical Laboratory | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Shiva Vairale
CSIR – National chemical Laboratory

Shiva Vairale
Affiliation CSIR – National Chemical Laboratory
Country India
Scopus ID 60050407800
Documents 6
Citations 9
h-index 3
Subject Area Drug Discovery
Event International Invention Awards
Google Scholar Rgn4SCoAAAAJ

Shiva Vairale is a researcher affiliated with the CSIR – National Chemical Laboratory in India, with research interests associated with biochemical sciences and drug discovery. Publicly indexed research records connect his work with bioactive molecules, natural products, biological macromolecules, antimicrobial investigations, and pharmacological applications. His research activities include collaborative studies addressing biologically relevant compounds and their potential therapeutic significance. Available publication records identify contributions to peer-reviewed research involving sericin-based nanotherapeutics and insect-derived metabolites, illustrating an interdisciplinary orientation spanning biochemistry, pharmacology, and translational drug-discovery research. [1]

Abstract

Shiva Vairale is a researcher at CSIR – National Chemical Laboratory whose documented work focuses on biochemical sciences, natural bioactive compounds, and drug discovery. His research profile includes investigations of biologically active molecules, therapeutic mechanisms, antimicrobial activity, and emerging nanotherapeutic approaches. Published work has addressed sericin-based formulations for anti-urolithiatic and antibacterial applications, while a recent review examines insect-derived metabolites and their pharmacological potential in modern drug discovery. These studies reflect an interdisciplinary research direction connecting biochemistry, natural products, pharmacology, molecular mechanisms, and translational applications. His indexed research record provides measurable indicators of scholarly activity and citation-based visibility.

Keywords

Shiva Vairale, Best Researcher Award, drug discovery, biochemical sciences, natural products, insect-derived metabolites, pharmacology, bioactive compounds, sericin nanotherapeutics, antimicrobial research, therapeutic applications, CSIR-National Chemical Laboratory, India.

Introduction

Drug discovery increasingly integrates natural-product chemistry, molecular biology, pharmacology, and advanced formulation strategies to identify biologically useful compounds. Within this multidisciplinary landscape, Vairale’s documented research is associated with the investigation of bioactive substances and their therapeutic relevance. His work at CSIR-National Chemical Laboratory places these activities within an established Indian research environment focused on chemical and biological sciences. [2] Recent publications further demonstrate engagement with natural metabolites and biological macromolecules as potential sources of pharmacological applications. [3]

Research Profile

Vairale’s research profile is situated primarily within biochemical sciences and drug discovery. Publicly available institutional and bibliographic information associates him with the Biochemical Sciences Division of CSIR-National Chemical Laboratory and with research involving bioactive compounds, biological assays, natural metabolites, and therapeutic applications. His academic record also places his doctoral research within biological sciences, supporting an interdisciplinary trajectory connecting chemical and biological investigation. [2]

Research Contributions

A documented contribution involves research on sericin-based nanotherapeutics, examining sericin and related nanoparticle formulations for anti-urolithiatic and antibacterial applications. The study combines biological macromolecules, nanotechnology, characterization, and pharmacological assessment. [1] Another contribution is a review of insect-derived metabolites in drug discovery, covering chemically diverse metabolites and their biological mechanisms while considering their translational relevance to pharmacotherapy. [4]

Publications

Vairale has contributed to peer-reviewed publications spanning natural products, biological macromolecules, antimicrobial research, and drug discovery. A notable publication is Sericin-based nanotherapeutics: A dual-action biological macromolecule for anti-urolithiatic and antibacterial applications, published in the International Journal of Biological Macromolecules in 2025 with DOI 10.1016/j.ijbiomac.2025.146763. [1] His 2026 review, Insect derived metabolites in drug discovery: Pharmacological potential, mechanisms, and translational challenges, appeared in Pharmacological Research – Natural Products, DOI 10.1016/j.prenap.2026.100808. [4]

Research Impact

The research addresses scientific questions relevant to therapeutic discovery, particularly the identification and characterization of biologically active substances. Work on sericin-based systems explores potential applications against urolithiasis and bacterial activity, while research concerning insect metabolites considers their broader pharmacological potential. These themes are relevant to continuing efforts to identify new biological resources and mechanisms for therapeutic development. The supplied bibliometric profile records six documents, nine citations, and an h-index of three. [1]

Award Suitability

For recognition under a Best Researcher Award category, the documented record provides evidence of peer-reviewed research activity, interdisciplinary subject engagement, and identifiable contributions to drug-discovery research. Relevant evidence includes publications involving biological macromolecules and natural metabolites, collaboration across research groups, and indexed bibliometric indicators supplied for this profile. The award record should be considered alongside the complete nomination materials and applicable evaluation criteria of the International Invention Awards. [5]

Conclusion

Shiva Vairale’s documented research activity reflects an interdisciplinary focus on biochemical sciences and drug discovery, with published work addressing sericin-based nanotherapeutics and insect-derived metabolites. His research connects natural bioactive resources with pharmacological investigation and potential therapeutic applications. The available bibliometric information and publication record provide a structured basis for describing his scholarly profile and its relevance to research recognition within the International Invention Awards.

References

  1. Elsevier. (n.d.). Scopus Author Details: Author ID 60050407800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60050407800
  2. Review article. (2026). Insect derived metabolites in drug discovery: Pharmacological potential, mechanisms, and translational challenges.
    https://doi.org/10.1016/j.prenap.2026.100808
  3. Research article. (2025). Sericin-based nanotherapeutics: A dual-action biological macromolecule for anti-urolithiatic and antibacterial applications.
    https://doi.org/10.1016/j.ijbiomac.2025.146763
  4. Google Scholar. (n.d.). Google Scholar author profile: Shiva Vairale. Google Scholar.
    https://scholar.google.com/citations?hl=en&user=Rgn4SCoAAAAJ
  5. International Invention Awards. (2026). International Invention Award.
    https://inventionawards.org/